European Companies Search Engine

Tips & Tricks
Our help pages Using the Quick Search and Power Search Overview explain how to use our search engine.

NovoCure GmbH, Munich, Germany

Watch

If you put a company on your watch list, we'll notify you on your email address when there are new publications regarding this company.

This feature is only available to our premium service subscribers.

Learn more about the North Data Premium Service

Dossier

The dossier is a printable PDF file, summarizing information and publications for this company. The creation of dossiers is included in your subscription. After the creation of the dossier is completed, it will be sent to your email address .

Add to dossier (if available):

This feature is only available to our premium service subscribers.

Learn more about the North Data Premium Service

Name

NovoCure GmbH

Identification

Ut
District Court of Munich HRB 233403
Ut
District Court of Frankfurt HRB 95264
Ut
District Court of Dusseldorf HRB 59632
EUID
DED2601V.HRB233403

Address

Elektrastr. 6, 81925 München, Germany
Frankfurt a. Main, Germany
Düsseldorf, Germany

Corporate purpose

Distribution and sale of medical devices and performance of the functions as authorised representative within the meaning of the Act on Medical Devices and Council Directive 93/42/EEC of 14 June 1993 on medical devices (OJ EC No. L 169 S 1). Activities subject to authorisation should only be taken up after a corresponding permit has been obtained.

Financial performance

Employees

For this company, Employees numbers are only available to our premium service subscribers.

Learn more about the North Data Premium Service

History

Persons

Marketing & Tech

Network

Loading network

Legal Structure

Current legal representatives (6)
This feature is only available to our premium service subscribers.

Learn more about the North Data Premium Service

JOBS AT NORTH DATA

  • Modern Java Developer

Financials

Key Performance Indicators: Financial (5) · Mktg & Tech (5)

The following indicators are on file for this company: Base/share capital · Total assets · Earnings · Earnings CAGR · Revenue · Revenue CAGR · Return on sales · Equity · Equity ratio · Return on equity · Employee number · Revenue per employee · Taxes · Tax ratio · Cash on hand · Receivables · Liabilities · Cost of materials · Wages and salaries · Average salaries per employee · Pension provisions · Trademarks

This feature is only available to our premium service subscribers.

Learn more about the North Data Premium Service

Publications

6 Mar 2026
Authorized signatory (ppa): Uri Weinberg
19 Jan 2026
Annual report for the year ending 31/12/2024 · Balance sheet for 31/12/2024 · Earnings statement for 31/12/2024 · Shareholder: NovoCure GmbH
17 Apr 2025
Authorized signatory (ppa): Sandra Ehrle, Julia Stindl · No longer Managing Director: Thomas Hefti, Tobias Daniel Weizel
26 Mar 2025
Original document: “Liste der Gesellschafter“
26 Mar 2025
Original document: “Liste der Gesellschafter“
24 Feb 2025
Annual report for the year ending 31/12/2023 · Balance sheet for 31/12/2023 · Earnings statement for 31/12/2023 · Shareholding: NovoCure GmbH
14 Mar 2024
Annual report for the year ending 31/12/2022 · Balance sheet for 31/12/2022 · Earnings statement for 31/12/2022 · Shareholding: NovoCure GmbH
21 Feb 2024
Managing Director: Thomas Hefti, Adrian Kinzel, Tobias Daniel Weizel · No longer Managing Director: Ashley Cordova, Wilco Groenhuysen · No longer Authorized signatory (ppa) (3)
13 Mar 2023
Annual report for the year ending 31/12/2021 · Balance sheet for 31/12/2021 · Earnings statement for 31/12/2021 · Shareholder: NovoCure GmbH
21 Jul 2022
Authorized signatory (ppa): Jürgen Otto Schaller
28 Jun 2022
Authorized signatory (ppa): Jacobus J. Hubregtse · No longer Authorized signatory (ppa) (1)
3 Nov 2021
Annual report for the year ending 31/12/2020 · Balance sheet for 31/12/2020 · Earnings statement for 31/12/2020
5 Mar 2021
Managing Director: Ashley Cordova · No longer Managing Director: Asaf Danziger
19 Feb 2021
Word figurative mark: “MyLink“
23 Sept 2020
Annual report for the year ending 31/12/2019 · Balance sheet for 31/12/2019 · Earnings statement for 31/12/2019
27 Mar 2020
Annual report for the year ending 31/12/2018 · Balance sheet for 31/12/2018
25 Dec 2019
Patent: REDUCING MOTILITY OF CANCER CELLS USING TUMOR TREATING FIELDS (TTFIELDS)
12 Dec 2019
Word figurative mark: “novocure“
5 Feb 2019
Word figurative mark: “NCOMPASS“
3 Jan 2019
Annual report for the year ending 31/12/2017 · Balance sheet for 31/12/2017
12 Jul 2018
Authorized signatory (ppa) (2) · No longer Authorized signatory (ppa) (1)
17 Apr 2018
Managing Director: Asaf Danziger, Wilco Groenhuysen · Authorized signatory (ppa) (1)
22 Mar 2018
Wordmark: “NOVOCURE“
8 Feb 2018
Annual report for the year ending 31/12/2016 · Balance sheet for 31/12/2016
11 Aug 2017
Patent: TEMPERATURE MEASUREMENT IN ARRAYS FOR DELIVERING TTFIELDS
29 Jun 2017
Patent: ARRAYS FOR LONGITUDINAL DELIVERY OF TTFIELDS TO A BODY
25 May 2017
Authorized signatory (ppa): Tobias Daniel Weizel
19 May 2017
Change of headquarters: NovoCure GmbH · Address · Seat: Munich, Germany
17 May 2017
MD: Asaf Danziger, Wilco Groenhuysen · ppa: Thomas Hefti, Tobias Weitzel · Change of headquarters: NovoCure GmbH · Address · Capital: €165,000 · Share­holder agreement · Company statute …
12 May 2017
Original document: “Liste der Gesellschafter“
10 May 2017
Original document: “Liste der Gesellschafter“
9 May 2017
Original document: “Gesellschaftsvertrag / Satzung / Statut“
4 Apr 2017
Patent: REDUCING MOTILITY OF CANCER CELLS USING TUMOR TREATING FIELDS (TTFIELDS)
7 Mar 2017
Annual report for the year ending 31/12/2015 · Balance sheet for 31/12/2015
23 Jan 2017
Authorized signatory (ppa): Thomas Hefti, Tobias Weitzel
28 Oct 2016
Patent: TTFIELD TREATMENT WITH OPTIMIZATION OF ELECTRODE POSITIONS ON THE HEAD BASED ON MRI-BASED CONDUCTIVITY MEASUREMENTS
21 Sept 2016
Original document: “Liste der Gesellschafter“
14 Jul 2016
Capital: €165,000 · Share­holder agreement
14 Jul 2016
Original document: “Liste der Gesellschafter“
15 Jun 2016
Original document: “Gesellschaftsvertrag / Satzung / Statut“
2 Apr 2015
Wordmark: “OPTUNE“
12 Feb 2015
Managing Director: Wilco Groenhuysen
6 May 2014
Patent: APPARATUS FOR TREATING A TUMOR WITH AN ALTERNATING ELECTRIC FIELD AND FOR SELECTING A TREATMENT FREQUENCY BASED ON ESTIMATED CELL SIZE
10 Mar 2014
Original document: “Liste der Gesellschafter“
15 Jan 2013
Original document: “Liste der Gesellschafter“
11 Dec 2012
Change of headquarters: NovoCure GmbH · Address
3 Dec 2012
Managing Director: Asaf Danziger · Change of headquarters: NovoCure GmbH · Address · Capital: €25,000 · Share­holder agreement · Proxy policy · Corporate Purpose
16 May 2012
Original document: “Gesellschaftsvertrag / Satzung / Statut“
4 May 2012
Annual report for the year ending 31/12/2011 · Balance sheet for 31/12/2011
14 Mar 2012
Annual report for the year ending 31/12/2008 · Balance sheet for 31/12/2008
12 Mar 2012
Annual report for the year ending 31/12/2009 · Balance sheet for 31/12/2009
12 Mar 2012
Annual report for the year ending 31/12/2010 · Balance sheet for 31/12/2010
12 Nov 2009
Address
14 Oct 2008
Reg­is­tra­tion · Managing Director: Asaf Danziger · Capital: €25,000 · Share­holder agreement · Proxy policy · Corporate Purpose
6 Aug 2008
Original document: “Liste der Gesellschafter“
24 Jul 2008
Original document: “Gesellschaftsvertrag / Satzung / Statut“
27 Jun 2008
Patent: TREATING BACTERIA WITH ELECTRIC FIELDS
There are no publications matching your search.

The data on this page is generated by a fully automated algorithm. It may have errors, and is provided on an "as is" basis with no guarantees of completeness, accuracy, usefulness or timeliness.

Printing is only available to North Data premium service subscribers.